INTRODUCTION {#sec0005}
============

Diffusion tensor imaging (DTI) has been used in recent years as a strong and non-invasive neuroimaging technique, which can provide useful information for detecting damage to white matter in neurodegenerative diseases by measuring the diffusion properties of water molecules \[[@ref001]\]. Four important quantitative measures of DTI are axial diffusivity (AxD), radial diffusivity (RD), mean diffusivity (MD), and fractional anisotropy (FA). FA describes the degree of anisotropy of water diffusion. MD is the average rate of diffusion along all directions and is typically increased with damage to myelin sheaths. AD is diffusion parallel to axons, while radial diffusivity (RD) reflects the two vectors of diffusion perpendicular to the axon \[[@ref003]\].

DTI tractography is a potential 3D tool for detecting white matter pathology and evaluating the microstructural integrity of white matter fiber bundles using information collected by DTI \[[@ref004]\] that was developed by Mori et al. \[[@ref005]\]. DTI and fiber tractography may be used in the diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI).

AD is the most prevalent form of dementia in the elderly population that caused by the presence of amyloid-β (Aβ) plaque and hyperphosphorylated tau protein as neurofibrillary tangles in the brain and finally cause neuronal death and damage to the brain tissue \[[@ref006]\].

MCI is a type of cognitive decline characterized by significant memory loss without functional impairments. Individuals with MCI do not fulfill the clinical criteria for dementia but they have a high risk for progression to dementia. This fact shows that the detection of MCI is important \[[@ref007]\]. It is believed that differential diagnosis of between normal subject and MCI and between MCI and AD are difficult and very important, and clinical neuroimaging techniques can be used to make these distinctions \[[@ref009]\].

AD and MCI affect certain regions of the brain. Therefore, the atlas-based method for the study of white matter integrity invariant regions of interest (ROI) has been widely used \[[@ref010]\]. Superficial white matter (SWM) is one of the regions that may play an important role in the diagnosis of AD \[[@ref011]\] and MCI.

SWM is located between gray matter and deep white matter and mainly consists of short-range association fibers (such as U-shaped fibers which connect neighboring gyri). The cellular and structural arrangement of the SWM differs from the deep white matter. For example, according to the retrogenesis model, fibers that myelinate later in development are the first to be affected by damage \[[@ref013]\]. The SWM, unlike the deep white matter, is comprised of late-myelinating fibers. Therefore, they are vulnerable to neurodegenerative processes. Furthermore, oligodendrocytes that produce the myelin sheath insulating neuronal axons tend to myelinate with fewer wraps in the SWM than the deep white matter. Accordingly, SWM axons are more sensitive to impairments \[[@ref011]\].

Recent studies showed decreased structural integrity and high sensitivity of SWM in multiple sclerosis \[[@ref015]\], autism \[[@ref016]\], schizophrenia \[[@ref017]\], Huntington's disease \[[@ref019]\], AD \[[@ref011]\], and cognitive decline in aging \[[@ref020]\]. According to our knowledge, no studies have assessed DTI values in this region in MCI.

There are many different methods for analyzing DTI data with their own advantages and restrictions. As different information and results are provided by different methods, performing more than one type of analysis is often valuable to earn insight into the results of each method \[[@ref022]\]. Methods used in recent studies include Tract-Based-Spatial-Statistics (TBSS) \[[@ref023]\], connectivity analysis \[[@ref024]\], voxel-based and ROI analyses \[[@ref028]\], tractography analysis \[[@ref018]\], and other methods. In the present study, we performed ROI and tractography approaches of the SWM region.

The purpose of the present study was the detection of SWM microstructural changes in AD and MCI using DTI through the region of interest and tractography techniques.

MATERIALS AND METHODS {#sec0010}
=====================

Clinical data and demographics {#sec0015}
------------------------------

Data used in the preparation of this article were obtained from the ADNI database (<http://adni.loni.usc.edu>). The ADNI was launched in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been to test whether serial MRI, positron emission tomography, other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of MCI and early AD. For up-to-date information, see <http://www.adni-info.org>.

The diffusion MRI, clinical, and neuropsychological data of subjects were downloaded from the ADNI database. Subjects including AD (*n* = 24), MCI (*n* = 24), and control (*n* = 24) groups were obtained from ADNI2 project ([Table 1](#adr-4-adr190149-t001){ref-type="table"}).

###### 

Demographics and clinical scores for the participants

                     NC (*n* = 24) Mean (SD)   MCI (*n* = 24) Mean (SD)   AD (*n* = 24) Mean (SD)       *p*
  ----------------- ------------------------- -------------------------- ------------------------- -------------
  Age                      75.3 (8.3)                  76 (8.6)                 76.4 (8.2)             0.89
  Sex                       11 M/13 F                 12 M/12 F                  16 M/8 F               0.3
  Global CDR               0.021 (0.1)               0.58 (0.19)                1.1 (0.116)         **\<0.001**
  FAQ Total Score          0.08 (0.4)                 4.9 (6.9)                 19.7 (6.2)          **\<0.001**
  MMSE                      29 (1.2)                   26.7 2)                  20.1 (4.9)          **\<0.001**

CDR, Clinical Dementia Rating; FAQ, Functional Activities Questionnaire; MMSE, Mini-Mental State Examination; NC, normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; M, male; F, female. *p* \< 0.05 was considered statistically significant and bold font indicates statistical significance.

Statement of ethics {#sec0020}
-------------------

The study was reviewed and approved by the Ethical Committee of Mashhad University of Medical Sciences (Ethical number: IR.MUMS.MEDICAL.REC.1397.320).

MRI and DTI scanning {#sec0025}
--------------------

The diffusion MRI data originated from ADNI2 project with the following parameters: Axial diffusion-weighted image data were acquired with an echo-planar imaging sequence. Scan parameters were: Manufacturer = GE MEDICAL SYSTEMS; field strength = 3.0T; Pulse Sequence = EP/SE flip angle = 90**°**; *b* = 1000 s/mm^2^; gradient directions = 41; pixel size = 1.36×1.36 mm^2^; repetition time (TR) = 9050 ms; echo time (TE) = 62.8 ms; slice thickness = 2.7 mm; Matrix *X* = 256.0 pixels; Matrix *Y* = 256.0 pixels; Matrix *Z* = 2714.0.

DTI processing {#sec0030}
--------------

### Preprocessing and reconstruction steps {#sec0035}

The diffusion MRI data were preprocessed using DSI-Studio software (developed by Fang-Cheng Yeh from the Advanced Biomedical MRI Lab, National Taiwan University Hospital, Taiwan, Supported by Fiber Tractography Lab, University of Pittsburgh, and made available at <http://dsi-studio.labsolver.org/Download/>). For skull stripping and filtering the background region, we used the masks provided by DSI-Studio. Prior to DTI parameter measurement, head motion and eddy current effects were corrected using the DSI-Studio toolbox. DSI Studio (<http://dsi-studio.labsolver.org>) supports several reconstruction methods and categorizes them into model-based and model-free methods. Model-based methods suppose a specific diffusion distribution pattern \[[@ref029]\]. In the present study, the DTI reconstruction approach performed as a model-based method and tensor calculation carried out by the linear equation system using least square fitting which can be a very effective and very fast tool in data analysis \[[@ref030]\].

Next, the average DTI values were extracted from voxels within the ROIs and tracts.

### ROI approach {#sec0040}

We used Superficial White Matter Mask which was obtained from a similar study \[[@ref018]\] in Montreal Neurological Institute (MNI) space ([Fig. 1](#adr-4-adr190149-g001){ref-type="fig"}). Based on the Terminologia Anatomica 1998 \[[@ref031]\] and Terminologia Neuroanatomical 2017 (FIPAT, Terminologia Neuroanatomica, FIPAT.library.dal.ca. Federative International Programme for Anatomical Terminology, February 2017) that divided cerebrum into 6 lobes, including frontal, parietal, temporal, occipital, limbic, and insular lobes. We divided these areas into right and left hemispheres for a more detailed review by the Talairach Atlas \[[@ref032]\] ([Fig. 2](#adr-4-adr190149-g002){ref-type="fig"}). In total, 12 SWM regions and average DTI values were calculated for each region.

![Three-plane view of whole brain Superficial White Matter Mask which was obtained from the similar study \[[@ref018]\] in Montreal Neurological Institute space.](adr-4-adr190149-g001){#adr-4-adr190149-g001}

![Overview of the division of the SWM of the brain into the frontal (pink), insula (green), limbic (yellow), parietal (blue), temporal (orange), occipital (Purple) lobes. a) 3D sagittal view b) 3D Axial View.](adr-4-adr190149-g002){#adr-4-adr190149-g002}

### Tractography approach {#sec0045}

FA index was used to determine the fiber tracking threshold and Otsu's method was used to set the anisotropy (FA) threshold to stop the fiber tracking. In other words, tracking was terminated if the anisotropy of the next step fell below the defined threshold. Then the tractography of each SWM region was performed with 100000 seeds was randomly generated at subvoxel positions and the seeds were placed across all SWM regions, step size of 0 (0.5 voxel to 1.5 voxel distance) and smoothing of 1. The tracking from the primary fiber of a seeding point was set to streamline (Euler), and the direction interpolation was set to trilinear. Fibers length range was set between 30 to 300 mm.

In order to obtain the exact fiber pathway of the region, The SWM mask was selected as ROI and the other areas of the brain defined as ROA (region of avoidance). Finally, with this method, fiber tracking restricted in the SWM mask (i.e., U-fibers and intraregional fibers) and all passing fibers through the exclusion region (ROA) mask were deleted. Examples of total SWM tracts are shown in [Figure 3](#adr-4-adr190149-g003){ref-type="fig"}. The average of the DTI measure, e.g., FA, is calculated from all voxels that are part of the delineated tract

![Example of SWM fibers pathways which generated by tractography of total SWM regions in standard MNI-ICBM152 template. Fibers pathways were recognized automatically according to an atlas-based tractography segmentation. (After performing the tractography of SWM regions, regions have been removed to better fibers pathways appear.)](adr-4-adr190149-g003){#adr-4-adr190149-g003}

Statistical analysis {#sec0050}
--------------------

We conducted between-group comparisons of demographic variables and neuropsychological scores using One-way analysis of variance (ANOVA) statistics for continuous variables (age and cognitive scores) and chi-squared tests for the qualitative variable (gender). After calculating the DTI values (FA, MD, RD, and AxD) per ROIs and along the extracted tracts as the response variables (dependent variables) in all three groups (independent variables), the normality of this data was assessed using the Kolmogorov-Smirnov test. Then for those variables in which normality assumption was satisfied, ANOVA with the *post hoc* multiple comparison (Bonferroni) test was used. In other words, ANOVA was first used to compare the means of the normal variables in the three groups. Subsequently, the pairwise *post-hoc* multiple comparison (Bonferroni) test was used to determine which of the two groups were significantly different in each value. The nonparametric method (Kruskal Wallis test) was used for non-normality values. Finally, spearman's correlation coefficients were performed between the Mini-Mental State Examination (MMSE) scores and DTI indices of SWM ROIs. *p*-value \<0.05 was considered statistically significant and all statistical analyses were performed using SPSS 24.0 software (SPSS Inc., Chicago, IL).

RESULTS {#sec0055}
=======

Subject demographics and clinical data {#sec0060}
--------------------------------------

Demographics and clinical scores of participants are shown in [Table 1](#adr-4-adr190149-t001){ref-type="table"}. Age and sex as the confounding variables (nuisance variables) were not significantly different between the normal controls (NC), MCI, and AD groups. MMSE, Functional Activities Questionnaire (FAQ) Total, and Global Clinical Dementia Rating (CDR) scores were significantly different between the three groups (MMSE scores: CN group versus MCI Group, *p* = 0.036; MCI group versus AD group, *p* \< 0.001; NC group versus AD group, *p* \< 0.001; FAQ Total scores: CN group versus MCI Group, *p* = 0.007; MCI group versus AD group, *p* \< 0.001; NC group versus AD group, *p* \< 0.001; Global CDR scores: CN group versus MCI Group, *p* \< 0.001; MCI group versus AD group, *p* \< 0.001; NC group versus AD group, *p* \< 0.001).

ROI analysis {#sec0065}
------------

ANOVA demonstrated a significant difference in AxD, MD, and RD values in many regions between the three groups (*p* \< 0.05). In contrast, the FA was not significantly different between the groups in none of the regions ([Table 2](#adr-4-adr190149-t002){ref-type="table"}).

###### 

Multiple comparisons of DTI measures of ROI (dependent variables) in MCI, AD, and control groups

                       CN Mean (SD)    MCI Mean (SD)   AD Mean (SD)       *p*
  ------------------- --------------- --------------- -------------- -------------
  **AxD**                                                            
    Left frontal        1.21 (0.12)     1.24 (0.08)    1.29 (0.12)       0.074
    Left insula        1.21 (0.17)\*    1.23 (0.11)    1.31 (0.11)     **0.026**
    Left limbic        1.37 (0.21)\*   1.52 (0.33)\*   1.75 (0.32)    **\<0.001**
    Left occipital      1.21 (0.16)     1.26 (0.16)    1.33 (0.19)       0.057
    Left parietal       1.25 (0.18)     1.26 (0.11)    1.26 (0.11)       0.054
    Left temporal      1.27 (0.14)\*   1.35 (0.17)\*   1.35 (0.17)    **\<0.001**
    Right frontal       1.22 (0.12)     1.26 (0.09)    1.26 (0.09)       0.051
    Right insula       1.26 (0.21)\*    1.31 (0.15)    1.31 (0.15)     **0.007**
    Right limbic       1.33 (0.19)\*    1.48 (0.35)    1.48 (0.35)     **0.001**
    Right occipital     1.19 (0.14)     1.19 (0.11)    1.19 (0.11)       0.19
    Right parietal      1.27 (0.19)     1.28 (0.13)    1.28 (0.13)       0.072
    Right temporal     1.24 (0.16)\*   1.31 (0.18)\*   1.31 (0.18)    **\<0.001**
  **MD**                                                             
    Left frontal        0.96 (0.11)     0.98 (0.07)    1.03 (0.11)       0.085
    Left insula        0.92 (0.11)\*    0.94 (0.08)    0.97 (0.08)     **0.038**
    Left limbic        1.04 (0.16)\*   1.19 (0.31)\*   1.36 (0.29)    **\<0.001**
    Left occipital     0.96 (0.13)\*    1.01 (0.14)    1.09 (0.17)     **0.013**
    Left parietal       0.99 (0.16)     1.01 (0.09)    1.08 (0.14)       0.061
    Left temporal      0.98 (0.11)\*   1.06 (0.14)\*   1.29 (0.18)    **\<0.001**
    Right frontal      0.95 (0.11)\*    1.01 (0.07)    1.03 (0.11)     **0.024**
    Right insula       0.97 (0.14)\*    1.02 (0.12)    1.12 (0.16)     **0.002**
    Right limbic       1.01 (0.15)\*    1.15 (0.33)    1.31 (0.29)     **0.001**
    Right occipital     0.95 (0.12)     0.96 (0.09)    1.02 (0.12)     **0.018**
    Right parietal     0.99 (0.18)\*    1.02 (0.11)    1.11 (0.14)     **0.043**
    Right temporal     0.96 (0.14)\*   1.03 (0.15)\*   1.23 (0.22)    **\<0.001**
  **RD**                                                             
    Left frontal        0.84 (0.11)     0.86 (0.11)    0.89 (0.11)       0.11
    Left insula         0.81 (0.11)     0.79 (0.11)    0.81 (0.08)       0.97
    Left limbic        0.91 (0.16)\*    1.02 (0.16)    1.17 (0.08)     **0.003**
    Left occipital      0.87 (0.14)     0.86 (0.13)    0.97 (0.16)       0.051
    Left parietal       0.88 (0.15)     0.87 (0.16)    0.94 (0.13)       0.13
    Left temporal      0.86 (0.11)\*   0.92 (0.11)\*   1.13 (0.17)    **\<0.001**
    Right frontal       0.84 (0.11)     0.87 (0.11)    0.91 (0.09)       0.074
    Right insula       0.85 (0.14)\*    0.88 (0.14)    0.96 (0.16)     **0.026**
    Right limbic       0.86 (0.14)\*    0.97 (0.15)    1.12 (0.29)     **0.005**
    Right occipital     0.85 (0.12)     0.85 (0.12)    0.91 (0.11)       0.21
    Right parietal      0.89 (0.16)     0.89 (0.18)    0.97 (0.14)       0.14
    Right temporal     0.84 (0.13)\*   0.89 (0.14)\*   1.08 (0.21)    **\<0.001**
  **FA**                                                             
    Left frontal        0.27 (0.02)     0.27 (0.01)    0.27 (0.02)       0.76
    Left insula         0.30 (0.05)     0.29 (0.04)    0.30 (0.05)       0.08
    Left limbic         0.28 (0.05)     0.27 (0.05)    0.28 (0.05)       0.32
    Left occipital      0.24 (0.02)     0.24 (0.02)    0.24 (0.02)       0.41
    Left parietal       0.26 (0.02)     0.27 (0.01)    0.26 (0.02)       0.57
    Left temporal       0.27 (0.02)     0.26 (0.01)    0.27 (0.02)       0.21
    Right frontal       0.28 (0.02)     0.27 (0.01)    0.28 (0.02)       0.31
    Right insula        0.28 (0.03)     0.26 (0.03)    0.28 (0.03)       0.26
    Right limbic        0.30 (0.04)     0.29 (0.03)    0.30 (0.04)       0.69
    Right occipital     0.24 (0.02)     0.24 (0.02)    0.24 (0.02)       0.78
    Right parietal      0.26 (0.02)     0.26 (0.01)    0.26 (0.02)       0.64
    Right temporal      0.27 (0.02)     0.26 (0.01)    0.27 (0.02)       0.09

Multiple comparisons of DTI measures of ROI in MCI, AD, and control groups. NC, normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; AxD, axial diffusion; MD, mean diffusion; RD, radial diffusion; FA, fractional anisotropy. *p* \< 0.05 was considered statistically significant and bold font indicates statistical significance. *Post-hoc* multiple comparison analysis: \*statistically significant versus AD; ^\#^statistically significant versus MCI.

### Group comparison between MCI and Control {#sec0070}

None of the DTI measures of SWM regions was significantly different between MCI and control groups.

### Group comparison between MCI and AD {#sec0075}

We found a significant increase in AxD values of the left limbic (*p* = 0.023), left and right temporal (*p* \< 0.001, *p* = 0.001) in the AD group compared to MCI. MD and RD values had a significant increase in the left and right temporal (MD: *p* \< 0.001, *p* = 0.001 and RD: *p* = 0.001, *p* = 0.001) in the AD group. In addition to the temporal lobe, MD value showed a significant difference in the left limbic (*p* = 0.043).

### Group comparison between control and AD {#sec0080}

Compared with control, AD subjects showed significant increases in AxD value of the left and right limbic (*p* \< 0.001), insula (*p* = 0.028, *p* = 0.008), and temporal (*p* \< 0.001) regions and MD value of the left and right limbic (*p* \< 0.001, *p* = 0.001), temporal (*p* \< 0.001), insula (*p* = 0.032, *p* = 0.001), right frontal (*p* = 0.02), and parietal (*p* = 0.047) regions and RD value of the left limbic (*p* = 0.003), temporal (*p* \< 0.001), right insula (*p* = 0.029), and right limbic (*p* = 0.003) regions.

Tractography analysis {#sec0085}
---------------------

AxD, RD, MD, and FA values extracted from SWM tracts and these parameters were significantly different between the three groups ([Table 3](#adr-4-adr190149-t003){ref-type="table"}).

###### 

Multiple comparisons of DTI measures of tractography (dependent variables) in MCI, AD, and control groups

                       CN Mean (SD)    MCI Mean (SD)   AD Mean (SD)       *p*
  ------------------- --------------- --------------- -------------- -------------
  **AxD**                                                            
    Left frontal        1.14 (0.12)     1.17 (0.08)    1.21 (0.16)       0.11
    Left insula        1.17 (0.17)\*    1.17 (0.11)    1.28 (0.16)     **0.009**
    Left limbic        1.18 (0.21)\*    1.24 (0.33)    1.34 (0.14)    **\<0.001**
    Left occipital     1.18 (0.16)\*    1.22 (0.16)    1.29 (0.18)     **0.041**
    Left parietal      1.13 (0.18)\*    1.21 (0.11)    1.23 (0.14)     **0.013**
    Left temporal      1.17 (0.14)\*    1.23 (0.17)    1.37 (0.17)    **\<0.001**
    Right frontal      1.16 (0.12)\*    1.19 (0.09)    1.24 (0.12)     **0.026**
    Right insula       1.15 (0.21)\*    1.27 (0.15)    1.26 (0.11)     **0.007**
    Right limbic       1.18 (0.19)\*    1.27 (0.35)    1.32 (0.12)     **0.001**
    Right occipital    1.16 (0.14)\*    1.22 (0.11)    1.27 (0.11)     **0.003**
    Right parietal     1.12 (0.19)\*    1.21 (0.13)    1.23 (0.11)     **0.006**
    Right temporal     1.15 (0.16)\*    1.22 (0.18)    1.29 (0.11)    **\<0.001**
  **MD**                                                             
    Left frontal        0.84 (0.07)     0.86 (0.06)    0.89 (0.09)       0.11
    Left insula        0.85 (0.12)\*    0.86 (0.06)    0.94 (0.13)     **0.003**
    Left limbic        0.89 (0.09)\*   0.94 (0.11)\*   1.02 (0.13)     **0.001**
    Left occipital     0.86 (0.08)\*    0.92 (0.11)    0.97 (0.14)     **0.009**
    Left parietal      0.81 (0.07)\*    0.88 (0.11)    0.88 (0.11)     **0.019**
    Left temporal      0.86 (0.06)\*   0.91 (0.08)\*   1.01 (0.15)    **\<0.001**
    Right frontal       0.86 (0.09)     0.88 (0.08)    0.92 (0.11)       0.11
    Right insula        0.86 (0.11)     0.95 (0.21)    0.93 (0.11)     **0.082**
    Right limbic       0.89 (0.08)\*    0.95 (0.12)    0.99 (0.11)     **0.007**
    Right occipital    0.86 (0.11)\*    0.91 (0.11)    0.94 (0.09)     **0.016**
    Right parietal     0.82 (0.09)\#    0.88 (0.14)    0.88 (0.08)     **0.027**
    Right temporal     0.85 (0.07)\*    0.92 (0.11)    0.96 (0.09)    **\<0.001**
  **RD**                                                             
    Left frontal        0.69 (0.07)     0.71 (0.06)    0.73 (0.09)     **0.021**
    Left insula        0.69 (0.12)\*    0.71 (0.06)    0.76 (0.12)     **0.012**
    Left limbic        0.75 (0.09)\*    0.78 (0.11)    0.85 (0.13)     **0.005**
    Left occipital      0.71 (0.09)     0.76 (0.11)    0.81 (0.13)       0.073
    Left parietal       0.66 (0.08)     0.72 (0.09)    0.71 (0.09)       0.067
    Left temporal      0.71 (0.07)\*    0.74 (0.08)    0.83 (0.14)    **\<0.001**
    Right frontal       0.71 (0.09)     0.73 (0.08)    0.76 (0.11)       0.19
    Right insula        0.71 (0.11)     0.81 (0.18)    0.77 (0.11)       0.051
    Right limbic       0.74 (0.09)\*    0.79 (0.11)    0.83 (0.11)     **0.015**
    Right occipital    0.71 (0.11)\*    0.76 (0.11)    0.78 (0.09)     **.034**
    Right parietal      0.67 (0.09)     0.74 (0.12)    0.71 (0.09)     **0.002**
    Right temporal     0.71 (0.07)\*    0.75 (0.08)    0.81 (0.09)   
  **FA**                   0.76                                      
    Left frontal        0.27 (0.02)     0.27 (0.01)    0.27 (0.02)       0.08
    Left insula         0.30 (0.05)     0.29 (0.04)    0.30 (0.05)       0.32
    Left limbic         0.28 (0.05)     0.27 (0.05)    0.28 (0.05)       0.41
    Left occipital      0.24 (0.02)     0.24 (0.02)    0.24 (0.02)       0.57
    Left parietal       0.26 (0.02)     0.27 (0.01)    0.26 (0.02)       0.21
    Left temporal       0.27 (0.02)     0.26 (0.01)    0.27 (0.02)       0.31
    Right frontal       0.28 (0.02)     0.27 (0.01)    0.28 (0.02)       0.26
    Right insula        0.28 (0.03)     0.26 (0.03)    0.28 (0.03)       0.69
    Right limbic        0.30 (0.04)     0.29 (0.03)    0.30 (0.04)       0.78
    Right occipital     0.24 (0.02)     0.24 (0.02)    0.24 (0.02)       0.64
    Right parietal      0.26 (0.02)     0.26 (0.01)    0.26 (0.02)       0.09
    Right temporal      0.27 (0.02)     0.26 (0.01)    0.27 (0.02)   

NC, normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; AxD, axial diffusion; MD, mean diffusion; RD, radial diffusion; FA, fractional anisotropy. *p* \< 0.05 was considered statistically significant and bold font indicates statistical significance. *Post-hoc* multiple comparison analysis: \*statistically significant versus AD; ^\#^statistically significant versus MCI.

### Group comparison between MCI and Control {#sec0090}

MD values had a significant increase in the right parietal SWM tracts only (*p* = 0.03) in the MCI group compared to the CN group and no significant difference was found in other regions and DTI measures.

### Group comparison between MCI and AD {#sec0095}

MD values had a significant increase in the left limbic (*p* = 0.048) and left temporal (*p* = 0.024) SWM tracts in the AD group.

### Group comparison between control and AD {#sec0100}

We found a significant increase in AxD value for the entire SWM region fibers except for the right frontal lobe fibers (*p* = 0.11) in the AD group.

MD value tracts in most regions of the brain included left and right limbic (*p* = 0.001, *p* = 0.005), left and right temporal (*p* \< 0.001), left and right occipital (*p* = 0.008, *p* = 0.013), left and right parietal (*p* = 0.04, *p* = 0.032), and left insula (*p* = 0.002) showed significant increases in the AD group compared to the CN group.

Also, RD value had significant increase in tracts of the left and right limbic (*p* = 0.004, *p* = 0.012), left and right temporal (*p* \< 0.001, *p* = 0.01), left and right occipital (*p* = 0.004, *p* = 0.033), and left insula (*p* = 0.01) in the AD group.

Correlations with MMSE {#sec0105}
----------------------

MMSE was significantly correlated with MD, RD, and AxD of parietal and temporal SWM in the AD group. There was no significant correlation between MMSE score and DTI indices in the control and MCI subjects ([Table 4](#adr-4-adr190149-t004){ref-type="table"}).

###### 

The correlation coefficient between superficial white matter AxD, MD, RD, FA, and MMSE scores

                       NC      MCI      AD                         
  ----- ----------- --------- ------ --------- ------ ------------ -----------
  AxD     frontal     0.07     0.74    .130     0.51     --0.24     **0.24**
          insula      0.05     0.80   --0.14    0.51     --0.37     0**.07**
          limbic     --0.05    0.81   --0.004   0.98     --0.45     **0.05**
         occipital    0.09     0.67   --0.18    0.37     --0.39     **0.05**
         parietal     0.05     0.78    0.02     0.92   **--0.42**   **0.04**
         temporal     --0.1    0.61    0.21     0.30   **--0.53**   **0.007**
  MD      frontal     0.12     0.55    0.19     0.36     --0.29     **0.16**
          insula      0.02     0.90   --0.25    0.23     --0.14     **0.50**
          limbic      0.12     0.56   --0.03    0.86     --0.39     **0.05**
         occipital    0.04     0.83   --0.12    0.54     --0.40     **0.05**
         parietal     0.11     0.59   --0.02    0.91   **--0.49**   **0.01**
         temporal     0.01     0.96    0.17     0.41   **--0.49**   **0.01**
  RD      frontal     0.07     0.72    0.14     0.50     --0.30     **0.14**
          insula     --0.004   0.98   --0.22    0.28     --0.02     **0.91**
          limbic      0.06     0.76   --0.003   0.98     --0.37     **0.07**
         occipital    0.09     0.65   --0.07    0.74     --0.39     **0.05**
         parietal     0.11     0.60   --0.02    0.90   **--0.51**   **0.01**
         temporal    --0.08    0.69    0.17     0.41   **--0.48**   **0.01**
  FA      frontal    --0.07    0.72   --0.28    0.17      0.12      **0.57**
          insula     --0.08    0.69    0.21     0.31      0.46      **0.06**
          limbic      --0.1    0.57    --0.1    0.63      0.19      **0.35**
         occipital    0.08     0.68   --0.11    0.58      0.29      **0.16**
         parietal     --0.2    0.32    0.002    0.99      0.37      **0.07**
         temporal     0.006    0.97     0.1     0.62      0.17      **0.41**

MMSE, Mini-Mental State Examination; AxD, axial diffusion; MD, mean diffusion; RD, radial diffusion; FA, fractional anisotropy; NC, normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease. *p* \< 0.05 was considered statistically significant and bold font indicates statistical significance.

DISCUSSION {#sec0110}
==========

Earlier studies in AD assessed whole-brain white matter that likely consisted of both SWM and deep white matter, but a few studies assessed only SWM.

SWM fibers included late myelinating fibers and are vulnerable to the neurodegenerative disease processes, based on the retrogenesis hypothesis \[[@ref012]\]. Therefore, we evaluated the SWM in MCI and AD groups in this study.

Our findings showed that AxD, MD, and RD values were higher in patients with AD in comparison with control subjects and these values were much more different than in FA. The results are consistent with two previous studies \[[@ref011]\]. They believed that increased axial diffusivity is associated with axonal damage and Wallerian degeneration in patients and increased RD is related to myelin sheath disruption and increased MD reflects the brain tissue atrophy. Accordingly, our findings also demonstrate brain tissue atrophy, Wallerian degeneration, and myelin sheath disruption in SWM in AD. The highest increase in MD values was seen in the left temporal and limbic regions (both increased by 32%), and in the left limbic region for AxD and RD values (28% and 44%, respectively) between ADr and control groups average an ROI approach.

On the other hand, SWM fiber tractography results also showed that the highest increase in AxD and RD values was in the left temporal (by 17%) and MD value increased in the left limbic (15%) in patients compared to the healthy controls. FA value was reduced in patients with AD in comparison with healthy controls and MCI subjects, but it was not statistically significant.

Tractography is a powerful tool for studying white matter pathways can be used for SWM fibers. These fibers often included short association U-fibers and intraregional fibers. In some studies \[[@ref033]\], short association fiber pathways (U-fibers) identified separately, but we evaluated all the fibers of SWM in any region in the present study.

To our knowledge, this is the first study evaluating the SWM changes in MCI using DTI. AxD, MD, and RD values were higher in MCI in comparison with control subjects. Nevertheless, we found a significant difference in MD value only in the right parietal SWM tracts.

These results are in agreement with a perfusion study that showed significant regional hypoperfusion in patients suffering from MCI compared to the CN group in the parietal lobe \[[@ref035]\]. Also in another study, the scores on the working memory domain correlated inversely with the parietal lobe atrophy score in MCI patients \[[@ref036]\], which confirms the damage to the parietal lobe in MCI patients, similar to our results.

Most studies reported DTI values changes in AD and MCI groups compared to the healthy controls and emphasized the earliest pathological changes in specific regions notably temporal lobe \[[@ref037]\]. Following these studies, we evaluated the SWM as a specific region that can help in the diagnosis of AD. Finally, compared to MCI, patients with AD had the highest increase in diffusivity values in the bilateral temporal lobe. In other words, the SWM of the temporal lobe in AD subjects can be a valuable biomarker for the detection of AD and MCI.

Previous studies have suggested the MMSE score as a useful tool for the identification of cognitive impairment in individuals with memory or other cognitive impairment \[[@ref010]\]. However, according to the results of the study by Phillips et al., the SWM microstructure may be vulnerable to age-related processes of demyelination \[[@ref020]\]. So, we detected associations between anatomic regions of SWM and MMSE score and we showed a significant association between changes in the axial, radial, and mean diffusivity of parietal and temporal SWM and the MMSE score in AD subjects. That is, in AD subjects, a decrease of the MMSE score was negatively associated with increased RD, MD, and AxD in temporal and parietal SWM (negative correlation). Phillips et al. believed that the correlation between SWM and MMSE suggested that the microstructural abnormalities could be seen as a manifestation of the disease evolution \[[@ref011]\]. Our findings showed a negative correlation between MMSE and diffusivity, which supports this conclusion.

Caution is needed when interpreting the results, since fiber architecture of superficial white matter containing multiple fiber populations (termed "crossing fibers"), reveals the more complex arrangement than in the deep white matter. The complex fiber arrangement can affect the estimation of the diffusion properties \[[@ref019]\]. For example, the FA value is strongly affected and is lower in such areas \[[@ref039]\] and similar results were reported by Wheeler-Kingshott et al. that demonstrated the challenges of interpreting changes in axial and radial diffusivity in crossing fiber regions \[[@ref040]\]. These created effects depend on the microstructure features of white matter pathways such as the degree of orientational coherence of fibers and pose severe challenges for tractography \[[@ref041]\]. Thus the interpretation of the diffusion data is complex and requires a prior knowledge about the architecture of the white matter pathways. Further research oriented on the anatomical specificity of superficial white matter architecture will help to complement DTI findings.

Conclusion {#sec0115}
==========

DTI offers a wide set of biomarkers for identifying and monitoring of the disease. Given that the DTI values changes in some regions of SWM, it can play an important role in the diagnosis of AD and MCI. To support this conclusion, we showed that there is major abnormality across the brain in patients and it is associated with MMSE score in AD subjects. So, the SWM microstructural changes are related to the clinical symptoms in AD.

Limitation {#sec0120}
----------

In the present study, DTI images were reconstructed with DTI as a model-based method. The results of model-based methods are limited by the model, while the diffusion pattern does not follow the assumption. A recent comparison study has shown that generalized q-sampling imaging is more accurate in voxels containing multiple fiber populations, compared to DTI reconstruction methods (e.g., crossing-fibers regions) \[[@ref042]\].
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